Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process
Published Date
Copyright 2005
DOI 10.2202/1558-9544.1013
You may be able to download this chapter for free via the Document Object Identifier.
-
Copy CitationErnst R. Berndt, Adrian H. B. Gottschalk, Tomas Philipson, and Matthew W. Strobeck, Frontiers in Health Policy Research, Volume 8 (Berkeley Electronic Press , 2005), chap. 1, https://www.nber.org/books-and-chapters/frontiers-health-policy-research-volume-8/assessing-impacts-prescription-drug-user-fee-acts-pdufa-fda-approval-process.Download Citation
Related
Published From Paper
-
Working Paper
Congress enacted and renewed the Prescription Drug User Fee Acts (PDUFA) in 1992, and renewed it in 1997 and 2002,...
More from the NBER
In addition to working papers, the NBER disseminates affiliates’ latest findings through a range of free periodicals—the NBER Reporter, the NBER Digest, the Bulletin on Health, the Bulletin on the Economics of Alzheimer's, and the Bulletin on Entrepreneurship—as well as research spotlights, lectures, and panel videos.
Mark Duggan, who is currently the Wayne and Jodi Cooperman Professor of Economics at Stanford University and will soon...
Research Associate Melissa Dell of Harvard University and Ashesh Rambachan of MIT delivered the 2026 Methods...
Supported by the Vanguard Group